WESTBROOK, Maine, Sept. 18, 2014 /PRNewswire/ -- IDEXX
Laboratories, Inc. (NASDAQ: IDXX) announces today the appointment
of Jacqueline L. Studer as Corporate
Vice President, General Counsel and Secretary, effective
September 1. Ms. Studer leads the
Legal, Compliance, Regulatory Affairs and Quality Assurance
groups.
"Jackie comes to us as a proven leader with exceptional
experience as a lawyer and business executive. She will be an
important leader in supporting IDEXX's growth, and I am pleased to
have her assume this role," said Jonathan
Ayers, Chairman and Chief Executive Officer.
Prior to joining IDEXX in June of this year, Studer was General
Counsel at Blue Health Intelligence, a healthcare data and
analytics company. Previously, she served as General Counsel at
Allscripts Healthcare Solutions, a publicly traded healthcare IT
company, and in several leadership positions at GE Healthcare, a
medical technology company, including as General Counsel of the GE
Healthcare IT and Performance Solutions division. She has extensive
experience in building and leading legal organizations to support
high-growth technology companies.
Studer earned a bachelor's degree in management from
Purdue and her J.D. at Columbia University School of Law.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a
leader in pet healthcare innovation, serving practicing
veterinarians around the world with a broad range of diagnostic and
information technology-based products and services. IDEXX products
enhance the ability of veterinarians to provide advanced medical
care, improve staff efficiency and build more economically
successful practices. IDEXX is also a worldwide leader in providing
diagnostic tests and information for livestock and poultry and
tests for the quality and safety of water and milk. Headquartered
in Maine, IDEXX Laboratories
employs more than 5,900 people and offers products to customers in
over 175 countries.
Note Regarding Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on management's current
expectations and beliefs, as well as a number of assumptions
concerning future events. These statements are subject to risks,
uncertainties, assumptions and other important factors. Readers are
cautioned not to put undue reliance on such forward-looking
statements because actual results may vary materially from those
expressed or implied. The reports filed by the Company pursuant to
United States securities laws
contain discussions of these risks and uncertainties. The Company
assumes no obligation to, and expressly disclaims any obligation
to, update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise. Readers are
advised to review the Company's filings with the United States
Securities and Exchange Commission (which are available from the
SEC's EDGAR database at www.sec.gov, at various SEC reference
facilities in the United States
and via the Company's website at www.idexx.com).
Contact: Ed Garber, Director,
Investor Relations, 1-207-556-8155
Logo -
http://photos.prnewswire.com/prnh/20110602/NE13041LOGO
SOURCE IDEXX Laboratories, Inc.